Page 99 - MI-2-1

Microbes & Immunity Hyphaene thebaica honey as a multitarget therapeutic product

chemometrics. Anal Chim Acta. 2005;533(2):185-191. the anticancer effects of p-coumaric acid: Focus on colorectal
cancer. Dose Response. 2023;21(1):15593258221150704.
doi: 10.1016/j.aca.2004.11.010
doi: 10.1177/15593258221150704
92. Yim SH, Kim HJ, Park SH, et al. Cytotoxic caffeic acid
derivatives from the rhizomes of Cimicifuga heracleifolia. 96. Singha K, Banerjee A, Jana A, et al. Molecular exposition
Arch Pharm Res. 2012;35(9):1559-1565. of broad-spectrum antibacterial efficacy by p-coumaric acid
from an edible mushroom Termitomyces heimii: In vitro and
doi: 10.1007/s12272-012-0906-0 in silico approach. SMAB. 2023;3(4):750-764.
93. Rajendra Prasad N, Karthikeyan A, Karthikeyan S, Reddy BV. doi: 10.1007/s43393-022-00146-z
Inhibitory effect of caffeic acid on cancer cell proliferation by
oxidative mechanism in human HT-1080 fibrosarcoma cell 97. Jiang L, Yang Y, Feng H, Zhou Q, Liu Y. Pinocembrin
line. Mol Cell Biochem. 2011;349(1-2):11-19. inhibits the proliferation, migration, invasiveness, and
epithelial-mesenchymal transition of colorectal cancer
doi: 10.1007/s11010-010-0655-7 cells by regulating LACTB. Cancer Biother Radiopharm.
94. Alam M, Ahmed S, Elasbali AM, et al. Therapeutic 2022;37(7):527-536.
implications of caffeic acid in cancer and neurological doi: 10.1089/cbr.2020.4052
diseases. Front Oncol. 2022;12:860508.
98. Cruz-Martins N. Advances in plants-derived bioactives for
doi: 10.3389/fonc.2022.860508 cancer treatment. Cells. 2023;12(8):1112.
95. Tehami W, Nani A, Khan NA, Hichami A. New insights into doi: 10.3390/cells12081112

Volume 2 Issue 1 (2025) 91 doi: 10.36922/mi.4994